Современные методы лечения рецидивного неоперабельного плоскоклеточного рака гортани (обзор литературы)

Современные методы лечения рецидивного неоперабельного плоскоклеточного рака гортани (обзор литературы)

Автор: Рожнов Виталий Анатольевич, Андреев Вячеслав Георгиевич, Гордон Константин Борисович, Гулидов Игорь Александрович, Акки Эрнест Диляверович

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Обзоры

Статья в выпуске: 2 (74), 2016 года.

Бесплатный доступ

В обзоре литературы представлены данные о современных методах лечения неоперабельного рецидивного плоскоклеточного рака гортани. Рассматриваются вопросы применения лучевой и лекарственной терапии.

Неоперабельный рак гортани, рецидив, паллиативное лечение, лучевая терапия, химиотерапия

Короткий адрес: https://sciup.org/14056676

IDR: 14056676   |   DOI: 10.21294/1814-4861-2016-15-2-90-100

Список литературы Современные методы лечения рецидивного неоперабельного плоскоклеточного рака гортани (обзор литературы)

  • Андреев В.Г., Мардынский Ю.С. Лучевое и комбинированное лечение рака гортани. М., 1998. 116 с.
  • Гервас П.А., Литвяков Н.В., Попова Н.О., Добродеев А.Ю., Тарасова А.С., Юмов Е.Л., Иванова Ф.Г., Черемисина О.В., Афанасьев С.Г., Гольдберг В.Е., Чердынцева Н.В. Проблемы и перспективы совершенствования молекулярно-генетической диагностики для назначения таргетных препаратов в онкологии//Сибирский онкологический журнал. 2014. № 2. С. 46-55.
  • Голдобенко Г.В., Ткачев С.И., Матякин Е.Г., Романов И.Г., Макаров С.П., Орлик О.П., Климаков Б.Д. Термолучевая терапия рецидивных метастазов рака верхних дыхательных и пищепроводных путей в лимфатических узлах//Российский онкологический журнал. 1997. № 6. С. 9-11.
  • Дарий В.А. Профилактика регионарных метастазов при раке гортани//Материалы III съезда онкологов и радиологов СНГ. Минск, 2004. Часть II. С. 10.
  • Завьялов А.А., Мусабаева Л.И., Лисин В.А., Чойнзонов Е.Л., Новиков В.А., Коломиец Л.А., Тузиков С.А., Афанасьев С.Г., Дубский С.В., Анисеня И.И., Тюкалов Ю.И., Миллер С.В., Добродеев А.Ю., Чивчиш Л.Н., Нечитайло М.Н., Жеравин А.А. Пятнадцатилетний опыт применения интраоперационной лучевой терапии//Сибирский онкологический журнал. 2004. № 2-3. С. 75-84.
  • Злокачественные новообразования в России в 2012 году (заболеваемость и смертность)/Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2014. 250 с.
  • Кисличко А.Г. Длительная внутриартериальная инфузионная химиотерапия в сочетании с локальной гипертермией при лечении нерезектабельного рака орофарингеальной зоны//Паллиативная медицина и реабилитация. 1999. № 2. С. 21.
  • Мухамедов М.Р., Черемисина О.В., Чойнзонов Е.Л., Кульбакин Д.Е., Балацкая Л.Н., Васильев Н.В., Гюнтер В.Э. Современный взгляд на комплексный подход к диагностике, лечению и реабилитации больных раком гортани//Российская оториноларингология. 2012. № 3. С. 78-84.
  • Пачес А.И. Опухоли головы и шеи. М., 2000. 480 с.
  • Сдвижков А.М., Борисов В.И., Солдатов И.В., Умеренков А.Г. Использование внутриартериальной регионарной химиотерапии в комплексном и паллиативном лечении больных с опухолями головы и шеи//Паллиативная медицина и реабилитация. 2001. № 2-3. С. 38.
  • Ткачев С.И., Любаев В.Л., Матякин Е.Г., Кондратьева А.П., Алиева С.Б., Зимина Н.А. Химиолучевая терапия плоскоклеточного рака головы и шеи//Материалы VII Российской онкологической конференции. М., 2003. С. 25-27.
  • Черниченко А.В., Решетов И.В., Едемская О.В. Результаты исследования по использованию метода интраоперационной лучевой терапии у больных злокачественными первичными и рецидивными местнораспространенными опухолями головы и шеи//Онкохирургия. 2008. № 2. С. 102.
  • Чойнзонов Е.Л., Старцева Ж.А., Мухамедов М.Р., Спивакова И.О., Черемисина О.В., Грибова О.В., Кульбакин Д.Е., Суркова П.В. Локальная гипертермия в комбинированном лечении рака гортани и гортаноглотки//Сибирский онкологический журнал. 2014. № 5. С. 5-12.
  • Шацкая Н.Х., Сдвижков А.М., Бяхов М.Ю. Возможности симптоматического лечения больных IV клинической группы с опухолями головы и шеи//Паллиативная медицина и реабилитация. 1999. № 2. С. 10.
  • Argiris A., Karamouzis M.V., Gooding W.E., Branstetter B.F., Zhong S., Raez L.E., Savvides P., Romkes M. Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer//J. Clin. Oncol. 2011. Vol. 29 (9). P.1140-1145. doi: 10.1200/JCO.2010.33.3591.
  • Armand J.P., Couteau C., Ramires Cintra F.J. ESMO meeting. Lisbon, 1994. P. 119-129.
  • Baselga J., Trigo J.M., Bourhis J., Tortochaux J., Cortés-Funes H., Hitt R., Gascón P., Amellal N., Harstrick A., Eckardt A. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinumrefractory metastatic and/or recurrent squamous cell carcinoma of the head and neck//J. Clin. Oncol. 2005. Vol. 23 (24). P. 5568-5577.
  • Benazzo M., Merlano M., Corvo R., Sanguineti G. Alternating concomitant chemo-radiotherapy with gemcitabine and cisplatin in advanced squamous cell carcinoma of head and neck; a feasibility study//Eighth Congress on Anti-Cancer Treatment. Paris. France, 1998. P. 92.
  • Biagioli M.C., Harvey M., Roman E., Raez L.E., Wolfson A.H., Mutyala S., Han H.S., Markoe A. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer//Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 69 (4). P. 1067-1073.
  • Bollet M.A., Lapeyre M., Marchal C., Hoffstetter S., Peiffert D., Cornes P.G., Luporsi E., Bey P. Cervical lymph node relapses of head and neck squamous cell carcinoma: is brachytherapy a therapeutic option?//Int. J. Radiat. Oncol. Biol. Phys. 2001. Vol. 51 (5). P. 1305-1312.
  • Bourhis J., Rivera F., Mesia R., Awada A., Geoffrois L., Borel C., Humblet Y., Lopez-Pousa A., Hitt R., Vega Villegas M.E., Duck L., Rosine D., Amellal N., Schueler A., Harstrick A. Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck//J. Clin. Oncol. 2006. Vol. 24 (18). P. 2866-2872.
  • Brockstein B., Haraf D.J., Rademaker A.W., Kies M.S., Stenson K.M., Rosen F., Mittal B.B., Pelzer H., Fung B.B., Witt M.E., Wenig B., Portugal L., Weichselbaum R.W., Vokes E.E. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitantchemoradiotherapy:A9-year, 337-patient,multi-institutional experience//Ann. Oncol. 2004. Vol. 15 (8). P. 1179-1186.
  • Burtness B., Goldwasser M.A., Mattar B., Forastiere A.A. Phase III Randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An Eastern Cooperative Oncology Group Study//J. Clin. Oncol. 2005. Vol. 23 (34). P. 8346-8654.
  • Chin R.K., Daly M.E., Maxim P.G. Salvage Re-irradiation using Intensity-modulated Radiotherapy for Squamous Cell Carcinoma of the Head and Neck//J. Radiat. Oncol. Biol. Phys. 2008. Vol. 72 (1). P. 420.
  • Choe K.S., Haraf D.J., Solanki A., Cohen E.E., Seiwert T.Y., Stenson K.M., Blair E.A., Portugal L., Villaflor V.M., Witt M.E., Vokes E.E., Salama J.K. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck Cancer treated with concurrent chemotherapy and reirradiation//Cancer. 2011. Vol. 117 (20). P. 4671-4678 DOI: 10.1002/cncr.26084
  • Choe K.S., Solanki F., Haraf D.J. Previous Chemoradiotherapy Predicts for Worse Survival in Patients Undergoing Chemo-reirradiation for Recurrent and Second Head and Neck Cancer//J. Radiat. Oncol. Biol. Phys. 2008. Vol. 72 (1). P. 378.
  • Cohen E.E. Novel therapeutic targets in squamous cell carcinoma of the head and neck // Semin. Oncol. 2004. Vol. 31 (6). P. 775-768. 28. Cohen E.E. Role of epidermal growth factor receptor pathway - targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck // J. Clin. Oncol. 2006. Vol. 24 (17). P. 2659-2665.
  • Cohen E.E. Role of epidermal growth factor receptor pathway -targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck//J. Clin. Oncol. 2006. Vol. 24 (17). P. 2659-2665.
  • Cohen E.E., Lingen M.W., Vokes E.E. The expanding role of chemotherapy in head and neck cancers//J. Clin. Oncol. 2004. Vol. 22 (9). P.1743-1752.
  • Colevas A.D. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck//J. Clin. Oncol. 2006. Vol. 24 (17). P. 2644-2652.
  • Cornes P.G., Cox H.J., Rhys-Evans P.R., Breach N.M., Henk J.M. Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction//Br. J. Surg. 1996. Vol. 83 (11). P. 1620-1622.
  • Dawson L.A., Myers L.L., Bradford C.R., Chepeha D.B., Hogikyan N.D., Teknos T.N., Terrell J.E., Wolf G.T., Eisbruch A. Conformal re-irradiation of recurrent and new primary head-and-neck cancer//Int. J. Radiat. Oncol. Biol. Phys. 2001. Vol. 50 (2). P. 377-385.
  • Domenge C., Pignon J.P., Sancho-Gamier H. Chemotherapy in locally advanced head and neck squamous cell carcinoma: results of a meta-analysis asing individual patient data of randomized trials//VIII Internal Congress on Anti-Cancer Treatment. Paris, France, 1998. P. 92.
  • Forastiere A.A., Shank D., Neuberg D., Taylor S.G. 4th, DeConti R.C., Adams G. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA390)//Cancer. 1998. Vol. 82 (11). P. 2270-2274.
  • Fury M.G., Sherman E., Lisa D., Algazy K., Brockstein B., Langer C., Lim D., Mehra R., Rajan S.K., Korte S., Lipson B., Yunus F., Tanvetyanon T., Smith-Marrone S., Ng K., Xiao H., Haque S., Pfister D.G.A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer//J. Natl. Compr. Canc. Netw. 2012. Vol. 10 (11). P. 1391-1398.
  • Gibson M.K., Li Y., Murphy B., Hussain M.H., DeConti R.C., Ensley J., Forastiere A.A. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trail of the Eastern Cooperative Oncology Group//J. Clin. Oncol. 2005. Vol. 23 (15). P. 3562-3567.
  • Grau J.J., Caballero M., Verger E., Monzó M., Blanch J.L. Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients//Acta Otolaryngol. 2009. Vol. 129 (11). P. 1294-1299 DOI: 10.3109/00016480802590451
  • Grimard L., Esche B., Lamothe A., Cygler J., Spaans J. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies//Head Neck. 2006. Vol. 28 (1). P. 888-895.
  • Herbst R.S., Arquette M., Shin D.M., Dicke K., Vokes E.E., Azarnia N., Hong W.K., Kies M.S. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck//J. Clin. Oncol. 2005. Vol. 23 (24). P. 5578-5587.
  • Hitt R., Amador M.L., Quintela-Fandino M., Jimeno A., del Val O., Hernando S., Cortes-Funes H. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck//Cancer. 2006. Vol. 106 (1). P. 106-111.
  • Horowitz E.M., Harris J., Langer C.J. Concurrent split course hyperfractionated radiotherapy, cisplatin, and paclitaxel in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck: Update of RTOG 9911//J. Clin. Oncol. 2005. Vol. 23. P. 519.
  • Hunter K.D., Parkinson E.K., Harrison P.R. Profiling early head and neck cancer//Nat Rev Cancer. 2005. Vol. 5 (2). P. 127-135.
  • Jacobs C., Lyman G., Velez-Garcia E., Sridhar K.S., Knight W., Hochster H., Goodnough L.T., Mortimer J.E., Einhorn L.H., Schacter L. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck//J. Clin. Oncol. 1992. Vol. 10 (2). P. 257-263.
  • Kasperts N., Slotman B., Leemans C.R., Langendijk J.A. A review on re-irradiation for recurrent and second primary head and neck cancer//Oral Oncol. 2005. Vol. 41 (3). P.225-243.
  • Kawecki A., Jagielska B., Falkowski S. Chemotherapy for metastatic or recurrent laryngeal cancer: tolerance and early results//Otolaryngol. Pol. 2000. Vol. 54. Suppl. 31. P. 21-23.
  • Kramer N.M., Horwitz E.M., Cheng J., Ridge J.A., Feigenberg S.J., Cohen R.B., Nicolaou N., Sherman E.J., Babb J.S., Damsker J.A., Langer C.J. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies//Head Neck. 2005. Vol. 27 (5). P. 406-414.
  • Langendijk J.A., Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions//Curr. Opin. Oncol. 2007. Vol. 19 (3). P. 202-209.
  • Latham M.M., Smart G.P., Hedland-Thomas B., Harper C.S. Endoluminal brachytherapy for recurrent laryngeal carcinoma//Australas Radiol. 1997. Vol. 41 (4). P. 357-360.
  • Lee N., Chan K., Bekelman J.E., Zhung J., Zhung J., Mechalakos J., Narayana A., Wolden S., Venkatraman E.S., Pfister D., Kraus D., Shah J., Zelefsky M.J. Salvage re-irradiation for recurrent head and neck cancer//Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (3). P. 731-740.
  • Leon X., Hitt R., Constenla M., Rocca A., Stupp R., Kovács A.F., Amellal N., Bessa E.H., Bourhis J. A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to platinum-based chemotherapy//Clin. Oncol. 2005. Vol. 17 (6). P. 418-424.
  • Levendaag P.C., Meeuwis C.A., Visser G.A. Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy//Radiother. Oncol. 1992. Vol. 23. P. 6-15.
  • Licitra L., Felip E. ESMO Guidelines Working Group. Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up//Ann. Oncol. 2009. Vol. 20 (Suppl. 4). P. 121-122.
  • Martinez-Trufero J., Isla D., Adansa J.C. Phase II study of capecitabine as palliative treatment for patients with squamous head and neck cancer with locoregional and/or metastatic relapse after previous platinum-based treatment: final results of Spanish Head and Neck Cancer Group//J. Clin. Oncol. 2009. Vol. 27 (15 Suppl). P. 312. (Abstr. 6047).
  • McLaughlin M.P., Parsons J.T., Fein D.A., Stringer S.P., Cassisi N.J., Mendenhall W.M., Million R.R. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx//Head Neck.1996. Vol. 18 (3). P. 229-235.
  • Misiukiewicz K., Bonomi M., Demicco E., Posner M. Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck//Ann. Oncol. 2014. Vol. 25 (8). P. 1667-1668 DOI: 10.1093/annonc/mdu194
  • Murar S., Forastiere A.A. Head and neck cancer: changing epidemiology, diagnosis, and treatment//Mayo Clin Proc. 2008. Vol. 83 (4). P. 489-501 DOI: 10.4065/83.4.489
  • Murphy B.A. Topoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck//Expert Opin. Pharmacother. 2005. Vol. 6 (1). P. 85-92.
  • Nag S., Schuller D.E., Martinez-Monge R., Rodriguez-Villalba S., Grecula J., Bauer C. Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies//Int. J. Radiat. Oncol. Biol. Phys. 1998. Vol. 42 (5). P. 1085-1089.
  • Nishino H., Tanaka H., Ishikawa K., Kanazawa T., Miyata M., Kitamura K. Combined chemotherapy with low-dose cisplatin, tegafur and uracil in a case with neck recurrence of laryngeal cancer//Gan To Kagaku Ryoho. 1998. Vol. 25 (12). P. 1973-1975.
  • Norris C.M., Peale A.R. Partial laryngectomy for irradiation failure//Arch. Otolaryngol. 1996. Vol. 84. P. 558-562.
  • Ohizumi Y., Tamai Y., Imamiya S., Akiba T. Complications following reirradiation for head and neck cancer//Am. J. Otol. 2002. Vol. 23 (4). P. 215-221.
  • Park S., Lee S., Park J. Phase II study of oral S-1 in pretreated patients with recurrent or metastatic head and neck cancer//J. Clin. Oncol. 2008. Vol. 26 (15 Suppl). P. 692 (Abstr. 17007).
  • Patel P.R., Salama J.K. Reirradiation for recurrent head and neck cancer//Expert Rev. Anticancer Ther. 2012. Vol. 12 (9). P. 1177-1189 DOI: 10.1586/era.12.97
  • Pazdur R., Coia R., Hoskins W. Cancer management: A multidisciplinary approach. Lawrence, KS: CMP Healthcare Media. 2005. P. 43-90.
  • Perry D.J., Chan K., Wolden S., Zelefsky M.J., Chiu J., Cohen G., Zaider M., Kraus D., Shah J., Lee N. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer//Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 76 (4). P. 1140-1146. doi: 10.1016/j. ijrobp.2009.03.025.
  • Rate W., Garrett P., Hamaker R., Singer M., Pugh N., Ross D., Haerr R., Charles G. Intraoperative radiation therapy for recurrent head and neck Cancer//Cancer. 1991. Vol. 67 (11). P.2738-2740.
  • Rwigema J.C., Heron D.E., Ferris R.L., Gibson M., Quinn A., Yang Y., Ozhasoglu C., Burton S. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience//Am. J. Clin. Oncol. 2010. Vol. 33 (3). P. 286-293. doi: 10.1097/COC.0b013e3181aacba5.
  • Salama J.K., Vokes E.E., Chmura S.J., Milano M.T., Kao J., Stenson K.M., Witt M.E., Haraf D.J. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary headand-neck squamous cell carcinoma//Int. J. Radiat. Oncol. Biol. Phys. 2006. Vol. 64 (2). P. 382-391.
  • Samlowski W.E., Moon J., Kuebler J.P., Nichols C.R., Gandara D.R., Ozer H., Williamson S.K., Atkins J.N., Schuller D.E., Ensley J.F. Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group phase II study//Cancer Invest. 2007. Vol. 25 (3). P. 182-188.
  • Schrijvers D., Vermorken J.B. Taxanes in the treatment of head and neck cancer//Curr Opin Oncol. 2005. Vol. 17. P.218-224.
  • Seiwert T.Y., Salama J.K., Vokes E.E. The concurrent chemoradiation paradigm-general principles//Nat. Clin. Pract. Oncol. 2007. Vol. 4 (2). P. 86-100.
  • Specenier P., Vermorken J.B. Targeted therapies in head and neck cancer//Target Oncol. 2007. Vol. 2. P. 73-78.
  • Spencer S.A., Harris J., Wheeler R.H., Machtay M., Schultz C., Spanos W., Rotman M., Meredith R. RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5 FU in patients with squamous cell cancer of head and neck//Int. J. Radiat. Oncol. Biol. Phys. 2001. Vol. 51 (5). P. 1299-1304.
  • Stewart J.S., Cohen E.E., Licitra L., Van Herpen C.M., Khorprasert C., Soulieres D., Vodvarka P., Rischin D., Garin A.M., Hirsch F.R., Varella-Garcia M., Ghiorghiu S., Hargreaves L., Armour A., Speake G., Swaisland A., Vokes E.E. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck //J. Clin. Oncol. 2009. Vol. 27 (6). P. 1864-1871 DOI: 10.1200/JCO.2008.17.0530
  • Sulman E.P., Schwartz D.L., Le T.T., Ang K.K., Morrison W.H., Rosenthal D.I., Ahamad A., Kies M., Glisson B., Weber R., Garden A.S. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes//Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (2). P. 399-409 DOI: 10.1016/j.ijrobp.2008.04.021
  • Trigo J., Hitt R., Korawalewski P. Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the nead and neck (SCCHN): result of a phase II study//Proc. ASCO. 2004. Vol. 23. P. 5502-5514.
  • Vargo J.A., Wegner R.E., Heron D.E., Ferris R.L., Rwigema J.C., Quinn A., Gigliotti P., Ohr J., Kubicek G.J., Burton S. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck//Head Neck. 2012. Vol. 34 (8). P. 1153-1161 DOI: 10.1002/hed.21889
  • Vermorken J.B., Psyrri A., Mesía R., Peyrade F., Beier F., de Blas B., Celik I., Licitra L. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial//Ann. Oncol. 2014. Vol. 25 (4). P. 801-807 DOI: 10.1093/annonc/mdt574
  • Vermorken J.B., Trigo J., Hitt R., Koralewski P., Diaz-Rubio E., Rolland F., Knecht R., Amellal N., Schueler A., Baselga J. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy//J. Clin. Oncol. 2007. Vol. 25 (16). P. 2171-2177.
  • Viani L., Stell P.M., Dalby J.E. Recurrence after radiotherapy for glottic carcinoma//Cancer. 1991. Vol. 67 (3). P. 577-584.
  • Watson J.C., Ridge J.A. Surgical management of local and regional recurrent head and neck squamous cell carcinoma//Curr. Opin. Oncol. 1998. Vol. 10 (3). P. 207-212.
  • Wenig B.L., Werner J.A., Castro D.J., Sridhar K.S., Garewal H.S., Kehrl W., Pluzanska A., Arndt O., Costantino P.D., Mills G.M., Dunphy F.R. 2nd, Orenberg E.K., Leavitt R.D. The Role of Intratumoral Therapy With Cisplatin/Epinephrine Injectable Gel in the Management of Advanced Squamous Cell Carcinoma of the Head and Neck//Arch. Otolaryngol. Head Neck Surg. 2002. Vol. 128 (8). P. 880-885.
  • Wong S.J., Machtay M., Li Y. Locally recurrent, previously irradiated head and neck cancer: Concurrent re-irradiation and chemotherapy, or chemotherapy alone?//J. Clin. Oncol. 2006. Vol. 24 (17). P. 2653-2658.
Еще
Статья обзорная
SciUp 2024 © 2024 ©